Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Psoriasis Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02694523
What this trial is testing

BI 655066/ABBV-066 (Risankizumab) Compared to Active Comparator (Adalimumab) in Patients With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
AbbVie 684
Large-scale testing (Phase 3)Study completedNCT03668613
What this trial is testing

Study to Assess the Long-term Safety, Tolerability, Efficacy of Secukinumab in Pediatric Patients of Age 6 to <18 Years, With Moderate to Severe Plaque Psoriasis

Who this might be right for
Moderate to Severe Chronic Plaque-type Psoriasis
Novartis Pharmaceuticals 84
Testing effectiveness (Phase 2)Active Not RecruitingNCT06301997
What this trial is testing

A Herbal Compound for Psoriasis

Who this might be right for
PsoriasisInflammationSkin Diseases
Fasa University of Medical Sciences 104
Testing effectiveness (Phase 2)Study completedNCT00150982
What this trial is testing

Alefacept Mechanism of Action in Psoriasis

Who this might be right for
Psoriasis
University of Medicine and Dentistry of New Jersey 9
Not applicableStudy completedNCT02626793
What this trial is testing

Otezla® in Patients With Plaque Psoriasis Under Routine Conditions

Who this might be right for
Psoriasis
Amgen 391
Not applicableNot Yet RecruitingNCT07481019
What this trial is testing

A Randomised Controlled Trial of ePROM-Guided Flexible Scheduling in Dermatology

Who this might be right for
Chronic Dermatological ConditionsEczemaUrticaria+2 more
National University Hospital, Singapore 250
Post-approval studies (Phase 4)Study completedNCT00512187
What this trial is testing

Moderate Weight Loss Makes Obese Patients With Severe Chronic Plaque Psoriasis Responsive to Sub-Optimal Dose of Cyclosporine: an Investigator Blinded, Controlled, Randomized Clinical Trial

Who this might be right for
Chronic Plaque PsoriasisObesity
Universita di Verona
Not applicableStudy completedNCT05046899
What this trial is testing

Investigation With BiopH+Psoriasis Medical Bath in Subject With Mild to Moderate Plaque Psoriasis.

Who this might be right for
Plaque Psoriasis
Biocool AB 25
Post-approval studies (Phase 4)Looking for participantsNCT07141004
What this trial is testing

Guselkumab Administered Subcutaneously in Treatment of Indian Participants With Psoriatic Arthritis (PsA)

Who this might be right for
Arthritis, Psoriatic
Johnson & Johnson Private Limited 100
Testing effectiveness (Phase 2)WithdrawnNCT02475304
What this trial is testing

Proof-of-concept Study of Forward Pharma (FP)187 in Patients With Mild/Moderate Psoriatic Arthritis

Who this might be right for
Psoriatic Arthritis
Skane University Hospital
Testing effectiveness (Phase 2)Study completedNCT00143806
What this trial is testing

Transitioning From Cyclosporine to Alefacept in Psoriasis

Who this might be right for
Psoriasis
University of Medicine and Dentistry of New Jersey 13
Not applicableEnded earlyNCT01156532
What this trial is testing

Clinical Effectiveness and Impact on Health-related Quality of Life in Peruvian Patients With Psoriasis After 16 Weeks of Adalimumab Therapy

Who this might be right for
Moderate to Severe Psoriasis
AbbVie (prior sponsor, Abbott) 30
Not applicableLooking for participantsNCT07298265
What this trial is testing

Physician- vs Questionnaire-Based Screening for Psoriatic Arthritis in Psoriasis

Who this might be right for
Psoriasis (PsO)Psoriatic Arthritis (PsA)
Charite University, Berlin, Germany 500
Not applicableStudy completedNCT03168347
What this trial is testing

Assessing Patient Confidence in Biologic Medications

Who this might be right for
Psoriasis
Wake Forest University Health Sciences 400
Post-approval studies (Phase 4)WithdrawnNCT03146247
What this trial is testing

Analysis of the Pathogenesis of Itch in Response to Apremilast Therapy in Psoriasis Patients

Who this might be right for
Moderate to Severe Plaque Psoriasis
Diamant Thaci
Testing effectiveness (Phase 2)Active Not RecruitingNCT05739435
What this trial is testing

Open-Label Extension Study to Evaluate the Long Term Safety and Efficacy of ESK-001 in Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Alumis Inc 165
Not applicableStudy completedNCT06101706
What this trial is testing

Assessment of Fatigue in Psoriatic Arthritis and Cutaneous Psoriasis Patients

Who this might be right for
Psoriatic ArthritisPsoriasis
Centre Hospitalier Henri Duffaut - Avignon 33
Not applicableStudy completedNCT04149587
What this trial is testing

Brodalumab (SILIQ®) in Psoriasis Participants With Inadequate Response to Their Current Biologic Agent Regimen

Who this might be right for
Psoriasis
Bausch Health Americas, Inc. 252
Early research (Phase 1)Study completedNCT01258088
What this trial is testing

Safety Study of Ointment for the Treatment of Plaque-type Psoriasis

Who this might be right for
Plaque-type Psoriasis
Pfizer 16
Not applicableNot Yet RecruitingNCT07398651
What this trial is testing

Apremilast and Adalimumab in Psoriatic Arthritis Patients

Who this might be right for
Psoriatic ArthritisUltrasound AssessmentTNF
Tanta University 60
Next Page